跳至主要内容
临床试验/JPRN-jRCTs031230071
JPRN-jRCTs031230071已完成Unknown

An Exploratory study of safety and efficacy of the new chemical peeling

ogita Toshitatsu0 个研究点目标入组 26 人开始时间: 2023年5月15日最近更新:

试验速览

阶段
Unknown
状态
已完成
发起方
入组人数
26

研究概览

简要总结

Increase in stratum corneum moisture content, confirming the peeling's action to improve stratum corneum moisture retention function. In the safety evaluation, these results suggest that the PLG-PML2-23-4 formulation is safe under normal use.

研究设计

研究类型
Interventional

入排标准

年龄范围
> 20age old 至 < 70age old(—)
性别
Female

入选标准

  • 1)Those who have expressed their willingness to participate in the study, understood the explanation, and agreed in writing to participate in the study
  • 2)Healthy Japanese women between the ages of 20 and 70 who wish to improve solar lentigines, freckle spots, chloasma, so-called dullness, and who do not meet the exclusion criteria, regardless of the presence or absence of diseases such as pigment spots
  • 3)Those who can fill in documents such as consent forms, questionnaires, usage diaries, etc.
  • 4)Those who can come to the facility on the designated observation day

排除标准

  • 1)Subjects who are likely to be exposed to sunlight during the test period (daytime sports, etc.)
  • 2)Subjects who are strongly aware of sensitive skin
  • 3)Those who have experienced allergic symptoms due to cosmetics etc
  • 4)Subjects with skin symptoms such as atopic dermatitis, seborrheic eczema, and vitiligo, and those with a history of them
  • 5)Subjects with coagulation disorder, immune disorder, facial herpes, severe acne, eczema, etc.
  • 6)Those with severe hay fever
  • 7)Subjects with a history of serious liver disorder, renal disorder, or myocardial infarction
  • 8)Those who are pregnant or during the study period, those who may become pregnant, and those who are breastfeeding
  • 9)Subjects who received facial, high-frequency treatment, injection treatment, etc. within 3 months from the start of the study
  • 10)Those who participated in other clinical trials, research, etc. within 6 months of the start of the trial
  • 11)Those who plan to participate in other clinical trials during the trial period
  • 12)Subjects with skin symptoms not suitable for chemical peeling on the face
  • 13)In addition, those who have symptoms that should be excluded by the attending physician or responsible physician

研究者

发起方
ogita Toshitatsu

相似试验